Pfizer/BioNTech vaccine approved for 12-15 year-olds

Swissmedic is extending approval for Pfizer/BioNTech's vaccine to prevent Covid-19 to adolescents aged 12 to 15, it announced on Friday. But the question of its usefulness for collective immunity and solidarity with poor countries is being debated.